| Schedule II: Valuation And Qualifying Accounts |
GILEAD SCIENCES, INC.
Schedule II: Valuation and Qualifying Accounts
(in thousands)
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Balance at Beginning of Period |
|
|
Additions/ Charged to Expense |
|
|
Deductions |
|
|
Balance at End of Period |
|
|
Year ended December 31, 2011: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable allowances (1) |
|
$ |
150,942 |
|
|
$ |
1,228,006 |
|
|
$ |
1,172,958 |
|
|
$ |
205,990 |
|
|
Valuation allowances for deferred tax assets (2) |
|
$ |
13,040 |
|
|
$ |
436 |
|
|
$ |
4,267 |
|
|
$ |
9,209 |
|
|
Year ended December 31, 2010: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable allowances (1) |
|
$ |
132,810 |
|
|
$ |
818,132 |
|
|
$ |
800,000 |
|
|
$ |
150,942 |
|
|
Valuation allowances for deferred tax assets (2) |
|
$ |
1,078 |
|
|
$ |
12,127 |
|
|
$ |
165 |
|
|
$ |
13,040 |
|
|
Year ended December 31, 2009: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable allowances (1) |
|
$ |
90,694 |
|
|
$ |
606,504 |
|
|
$ |
564,388 |
|
|
$ |
132,810 |
|
|
Valuation allowances for deferred tax assets (2) |
|
$ |
— |
|
|
$ |
15,103 |
|
|
$ |
14,025 |
|
|
$ |
1,078 |
|
|